Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1148/radiol.2453061538
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tateishi, U.
Right arrow Articles by Kim, E. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tateishi, U.
Right arrow Articles by Kim, E. E.
(Radiology 2007;245:839-847.)
© RSNA, 2007


Nuclear Medicine

Bone and Soft-Tissue Sarcoma: Preoperative Staging with Fluorine 18 Fluorodeoxyglucose PET/CT and Conventional Imaging1

Ukihide Tateishi, MD, Umio Yamaguchi, MD, Kunihiko Seki, MD, Takashi Terauchi, MD, Yasuaki Arai, MD, and E. Edmund Kim, MD

1 From the Division of Diagnostic Radiology (U.T., Y.A.), Division of Orthopedic Oncology (U.Y.), and Clinical Laboratory (K.S.), National Cancer Center Hospital, Tokyo, Japan; Division of Cancer Screening, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan (T.T.); and Division of Diagnostic Imaging, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1264, Houston, TX 77030 (U.T., E.E.K.). Received September 5, 2006; revision requested November 10; revision received November 20; accepted January 8, 2007; final version accepted April 2. Supported in part by grants from Scientific Research Expenses for Health and Welfare Programs, No. 17-12, the Promotion and Standardization of Diagnostic Accuracy in PET/CT Imaging, the Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare, and a Travel Grant from the Princess Takamatsu Cancer Research Fund. Address correspondence to U.T. (e-mail: utateish{at}ncc.go.jp).

Purpose: To retrospectively compare the diagnostic accuracy of positron emission tomography (PET)/computed tomography (CT), PET, conventional imaging, and combined PET/CT and conventional imaging for tumor staging of bone and soft-tissue sarcomas, by using histologic or follow-up imaging findings as the reference standard.

Materials and Methods: Institutional review board approval was received for this HIPAA-compliant study; informed consent was obtained. Integrated PET/CT was performed in 117 patients (69 male patients, 48 female patients; mean age, 42 years ± 21 [standard deviation]; range, 9–86 years). Conventional imaging consisted of magnetic resonance imaging of the primary site, chest radiography, whole-body contrast material–enhanced CT, and bone scintigraphy. A total of four reviewers assessed all images. Overall and T staging were evaluated in 69 (59%) patients who underwent surgical removal of the primary tumors and had pathologically proved results. N and M staging were evaluated in all patients, and their reference methods were based on histologic findings (n = 101) and follow-up CT findings (n = 16).

Results: Interpretations based on combined PET/CT and conventional imaging findings correctly staged tumors in 60 (87%) of 69 patients, overstaged tumors in eight (12%) patients, and understaged tumors in one (1%) patient. Overall staging accuracy of combined PET/CT and conventional imaging was significantly higher than that at PET (P < .0001). Combined PET/CT and conventional imaging resulted in correct N staging in 114 (97%) of 117 patients and M staging in 109 (93%) of 117 patients. Combined PET/CT and conventional imaging helped reduce overstaging in three (4%) patients and helped change tumor diagnosis from unresectable to resectable in two (2%) patients compared with PET/CT.

Conclusion: The combination of PET/CT and conventional imaging is accurate in preoperative staging of bone and soft-tissue sarcoma.

© RSNA, 2007




This article has been cited by other articles:


Home page
RadiologyHome page
Y. Ohno, H. Koyama, Y. Onishi, D. Takenaka, M. Nogami, T. Yoshikawa, S. Matsumoto, Y. Kotani, and K. Sugimura
Non-Small Cell Lung Cancer: Whole-Body MR Examination for M-Stage Assessment--Utility for Whole-Body Diffusion-weighted Imaging Compared with Integrated FDG PET/CT
Radiology, August 1, 2008; 248(2): 643 - 654.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2007 by the Radiological Society of North America.